Public signalCompany raiseAuto-indexed · Unverified
Prolifagen, Inc. raised $3.0M
Prolifagen, Inc.· DOYLESTOWN, US· Biotechnology· Filed Sep 23, 2025
Prolifagen, Inc. reported raising capital. Based in DOYLESTOWN, PENNSYLVANIA, US. First sale reported 2025-09-02. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$3.0M
Confidence90%
Raised
$3.0M
Investors
6
Incorporated
2025
Jurisdiction
DELAWARE
On the record
- Location
- DOYLESTOWN, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $3.0M
- Filing date
- Sep 23, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2025
- Industry group
- Biotechnology
- Number of investors
- 6
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- Indefinite
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 3,026,864 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Sep 23, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with Prolifagen, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record